pharma impact post
factor need better understood continu favor
thu far much focu near-term impact less clear pictur
gone coverag lower out-year forecast compani
mid/larg cap coverag billion market cap initi lower ep averag
ex-prgo rais modestli driven discuss investor push-back
whether linger impact post see dissip post still
clear expect clear impact beyond host factor detail look
anoth possibl sharp step-up unemploy data increas attent overal see
compani spare least impact manag continu highlight
top defens idea latter potenti benefit see recessionari shift
privat label past near-term over-the-counter stock-pil help support
unemploy data like inflect meaning inform shift futur healthcar
coverag landscap last week unemploy number million may look light compar
week still revis higher translat perceiv loss commerci employ
insur one two thing shift larg portion popul commerci public
payor weigh net reimburs and/or ii reduc number insur
recessionari environ would direct patient behavior away less critic elect
treatment lower price option think matter product portfolio focu
high price elect product like see pressur downturn reduc coverag option
less pocket discretionari spend influenc behavior demand could weigh
volum variou product line think seen past downturns/recess
would expect demand lower price over-the-counter store brand option increas along market
share would posit part core thesi link
clinic trial impact broad risk goe beyond enrol suspens
signific disrupt fda provid guidanc link flexibl around protocol deviat
well defin creat concern concern around trial disrupt one
theme virtual doc day today link includ feedback around lack clariti fda trust
around much flexibl afford someth heard other well
launch curv push hurt other telemedicin
clearli trend face face visit ii virtual sale rep like least
effect person sale call survey work point volum area
lower area see demand bounc back think mani treatment
effect flatten up-tak curv carry-ov impact outer year
respons domest foreign govern off-set unpreced
cost far clear us partial govern pay foreign govern buyer
pharmaceut presenc deep budgetari pressur could see pressur
new either back saw meaning eu auster measur pressur gener drug price
region china japan introduc drug price reform drug price debat temper
biopharma pursu solut post risk could clearli come back
price prior trade day market close estimate unless otherwis note
valu usd unless otherwis note
pharma impact post
analyst respons prepar research report receiv compens base upon variou factor includ
total revenu member compani capit market affili portion gener
invest bank activ member compani capit market affili
pleas note current conflict disclosur may differ public date set forth
report access current conflict disclosur client refer http //www rbccm com/gldisclosure/publicweb/
send request cm research publish bay street royal bank plaza
member compani capit market one affili manag co-manag public offer secur
inc past month
member compani capit market one affili receiv compens invest bank servic
pfizer inc past month
capit market llc make market secur pfizer inc
member compani capit market one affili receiv compens product servic
invest bank servic pfizer inc past month time member compani capit
market one affili provid non-secur servic pfizer inc
capit market current provid pfizer inc non-secur servic
capit market provid pfizer inc invest bank servic past month
capit market llc make market secur perrigo compani public limit compani
explan capit market equiti rate system
explan capit market high yield rate system
analyst sector univers compani analyst provid research coverag accordingli rate assign
particular issu repres sole analyst view issu perform next month rel
outperform provid superior rel risk-reward ratio and/or expect materi outperform sector averag
sector perform sp provid adequ rel risk-reward ratio and/or total return expect line sector
averag month
under-perform provid inferior rel risk-reward ratio and/or total return expect materi lag sector averag
month
restrict polici preclud certain type commun includ invest recommend
act advisor certain merger strateg transact certain circumst
rate nr rate estim remov due applic legal regulatori polici constraint may
includ capit market act advisori capac involv compani
march capit market discontinu top pick rate top pick rate secur repres analyst best
idea sector expect provid signific absolut return month favor risk-reward ratio top pick
rate secur reassign outperform rate secur categori secur expect materi
outperform sector averag month
pharma impact post
distribut rate
purpos rate distribut regulatori rule requir member firm assign rate one three rate categori
 buy hold/neutr sell regardless firm rate categori although capit market rate outperform
sector perform sp under-perform close correspond buy hold/neutr sell respect mean
rate determin rel basi
distribut rate
rate price target histori pfizer inc us usd
tp top pick outperform sp sector perform under-perform restrict initi research coverag discontinu research coverag
nr rate na avail rl recommend list rl refer date secur place recommend list rl refer date
secur remov recommend list rtg rate
creat bluematrix
rate price target histori perrigo compani public limit compani us usd
tp top pick outperform sp sector perform under-perform restrict initi research coverag discontinu research coverag
nr rate na avail rl recommend list rl refer date secur place recommend list rl refer date
secur remov recommend list rtg rate
creat bluematrix
pharma impact post
refer recommend list recommend histori chart may includ one recommend list model
portfolio maintain wealth manag one affili wealth manag recommend list includ
guid portfolio prime incom rl guid portfolio dividend growth rl guid portfolio adr rl
guid portfolio cap growth rl capit market recommend list includ strategi focu list
fundament equiti weight portfolio abbrevi rl mean date secur place
recommend list abbrevi rl mean date secur remov recommend list
equiti valuat risk
valuat method use determin risk may imped achiev price target cover compani pleas
see recent company-specif research report http //www rbcinsightresearch com send request capit
price target base blend price-to-earnings ev/ebitda multipl use cy estim assum multipl
respect taken histor averag global consum multipl price-to-earnings ev/ebitda
made adjust base company-specif attribut private-label discount earn momentum gener busi discount
litig risk collect result valuat discount impli return price target support outperform
risk rate price target
organ revenu growth consum self-car america segment soften due weaker-than-expect over-the-counter market
growth greater-than-expect price eros
delay fda approv gener drug applic result declin revenu and/or margin rx segment
unexpect meaning competit entri us store brand over-the-counter rx busi
price target base equal price-to-earnings ev/ebitda estim reflect stand-alone number follow
close upjohn spin use multipl respect get us add per share
reflect valu ownership stake mylan/upjohn newco multipl use reflect price target
framework appli premium histor industri averag reflect factor includ compani higher
dividend yield growth profil other impli return price target support outperform rate
risk rate price target
risk rate price target includ limit tail valu risk loss exclus loe concern key
product start beyond pipelin risk beyond initi key driver sustain
growth acquisit risk compani continu activ bd posit long-term growth
regulatory/polit risk broadli applic sector particularli around pricing/reimburs
capit market polici manag conflict interest relat invest research avail us request
access current polici client refer
send request capit market research publish bay street royal bank plaza floor south
tower toronto ontario reserv right amend supplement polici time
pharma impact post
dissemin research short-term trade idea
capit market endeavor make reason effort provid research simultan elig client
regard local time zone oversea jurisdict capit market equiti research post proprietari websit
ensur elig client receiv coverag initi chang rate target opinion time manner addit
distribut may done sale personnel via email fax electron mean regular mail client may also
receiv research via third parti vendor capit market also provid elig client access sparc firm
proprietari insight websit via email via third-parti vendor sparc contain market color commentari regard
subject compani firm current provid equiti research coverag research analyst may time time
includ short-term trade idea research report sparc short-term trade idea offer short-term view
secur may trade base market trade event result trade opportun may avail
short-term trade idea may differ price target recommend publish research report reflect
research analyst view long-term one year prospect subject compani result differ time horizon
methodolog and/or factor thu possibl subject compani common equiti consid long-term
sector perform even under-perform might present short-term buy opportun result temporari sell pressur
market convers subject compani common equiti rate long-term outperform could consid suscept
short-term downward price correct short-term trade idea rate part rate system
firm gener intend undertak oblig maintain updat short-term trade idea short-term trade
idea may suitabl investor tailor individu investor circumst object
investor make independ decis regard secur strategi discuss herein pleas contact
invest advisor institut salesperson inform regard capit market research
list recommend compani dissemin prior period pleas click
month histori sparc view http //www rbcinsightresearch com
view express report accur reflect person view respons analyst
subject secur issuer part compens respons analyst name herein directli
indirectli relat specif recommend view express respons analyst report
global industri classif standard gic develop exclus properti servic mark inc standard poor financi servic
llc licens use neither parti involv make compil gic gic classif make express impli
warranti represent respect standard classif result obtain use thereof parti herebi expressli disclaim warranti
origin accuraci complet merchant fit particular purpos respect standard classif without limit forego
event shall affili third parti involv make compil gic gic classif liabil direct indirect special
punit consequenti damag includ lost profit even notifi possibl damag
refer herein libor libo rate libor abbrevi mean london interbank offer rate administ benchmark administr
person take administr rate
capit market busi name use certain branch subsidiari royal bank canada includ dominion secur inc
capit market llc europ limit royal bank canada hong kong branch royal bank canada sydney branch inform contain
report compil capit market sourc believ reliabl represent warranti express impli made royal
canada capit market affili person accuraci complet correct opinion estim contain
report constitut capit market judgement date report subject chang without notic provid good faith without
legal respons noth report constitut legal account tax advic individu tailor invest advic materi prepar gener
circul client prepar without regard individu financi circumst object person receiv invest
servic contain report may suitabl recommend consult independ invest advisor doubt
suitabl invest servic report offer sell solicit offer buy secur past perform guid
futur perform futur return guarante loss origin capit may occur capit market research analyst compens base
part overal profit capit market includ profit attribut invest bank revenu everi provinc canada state
 countri throughout world law regul type secur invest product may offer
resid well process result secur discuss report may elig sale jurisdict capit
market may restrict publish research report time time due regulatori restrict and/ intern complianc polici case
latest publish research report avail client may reflect recent materi chang applic industri and/or applic subject compani
capit market research report current date set forth research report report circumst
pharma impact post
constru solicit act secur broker dealer jurisdict person compani legal permit carri busi
secur broker dealer jurisdict full extent permit law neither capit market affili person accept
liabil whatsoev direct indirect consequenti loss aris connect use report inform contain herein
matter contain document may reproduc copi mean without prior written consent capit market instanc
addit inform avail request
public approv capit market llc member finra nyse sipc regist broker-deal accept
respons report dissemin unit state recipi report regist broker-deal bank act
broker dealer capac wish inform regard effect transact secur discuss report
contact place order capit market llc
public approv dominion secur inc member iiroc canadian recipi report design institut
ontario accredit investor british columbia alberta sophist purchas quebec similar permit purchas provinc
wish inform regard effect transact secur discuss report contact place order
dominion secur inc without way limit forego accept respons report dissemin canada
public approv europ limit el author prudenti regul author regul
conduct author fca prudenti regul author connect distribut unit kingdom materi gener
distribut unit kingdom retail client defin rule fca rbcel accept respons report dissemin
unit kingdom
materi distribut germani europ limit frankfurt branch regul bundesanstalt fr finanzdienstleistungsaufsicht bafin
receiv advic australia
materi distribut australia royal bank canada sydney branch abn afsl materi prepar
gener circul take account object financi situat need recipi accordingli recipi act
materi consid appropri materi regard object financi situat need materi relat acquisit
possibl acquisit particular financi product recipi australia obtain relev disclosur document prepar respect product
